The study on super selective hepatic artery embolization for effects of hepatic cyst volume and liver function of symptomatic patients with polycystic liver
10.3969/J.ISSN.1672-8270.2016.08.017
- VernacularTitle:超选择性肝动脉栓塞对症状性多囊肝患者囊肿体积和肝功能的影响
- Author:
Jianhong ZHANG
;
Xianfang GUO
- Publication Type:Journal Article
- Keywords:
Artery embolization;
Polycystic liver;
Cyst volume;
Liver function
- From:
China Medical Equipment
2016;13(8):57-59,60
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the super selective transhepatic arterial embolization (TAE) for effects of cyst volume and liver function in patients with symptomatic polycystic liver disease (PLD), and provide a reliable basis for clinical diagnosis and treatment. Methods: 14 cases of symptomatic patients with PLD were selected from October 2014 to October 2015 in our hospital using super selective hepatic arterial embolization. The upper abdomen was performed CT scan one year after surgery, and the volume of patients with liver cyst was tested. We observed the changes of total volume of liver before TAE and postoperative kidney function, adverse reactions, and the improvements after four months’ follow-up.Results: The angiography for the 14 patients showed liver volume increased in different degrees. It also showed that blood supply was mainly hepatic artery wall branch. There were different sizes of liver round unstained area. There was consistent between CT examination and unstained area in polycystic liver swollen area. The difference of the total volume of the liver cyst was statistically significant in 14 cases of the patients with PLD before TAE treatment and after 12 months’ treatment (t=2.8627,P<0.05). 14 cases of the patients with PLD after TAE before treatment and after 1 week’s laboratory tests, the difference was not statistically significant among AST, ALT, ALB and TBIL (t=0.0441,t=0.3316,t=0.0722,t=1.9855;P>0.05). Compared with the preoperative, there was little effect on liver function by TAE. After 3 to 12 months, symptoms gradually improved and physical rating increased. The improvement rate was 100% after 12 months and the physical score was from 90 to 100 points. The embolism syndrome in 14 cases of patients gradually disappeared after 1 to 5 days, and five days later the symptoms disappeared. Conclusions: There is a significant effect for symptomatic polycystic liver patients with TAE. It can improve efficacy and reduce patient suffering with a low recurrence rate. It is worthy of clinical application.